Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

New treatments like nanotechnology show promise in improving skin cancer therapy.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

A group has developed therapies that show promise for treating cancer and various other conditions.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Older skin has higher cancer risk due to inflammation and stem cell issues.

New cancer treatments aim to reduce side effects and improve effectiveness.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

Nanotechnology shows promise for better drug delivery and cancer treatment.